he pandemic accelerated many sponsors to embrace decentralized clinical trial (DCT) elements for their studies faster than originally intended, demonstrating real benefits to patients, sites, and sponsors. For all the benefits DCT technology and services bring, they present additional complexities related to patient data privacy and regulatory compliance adherence that are critical align.